BKV Corp (BKV) · Sep 10, 2026 · New debt
$500M convertible financing — Offering upsized to $500M from $400M
BKV priced $500M of 1.625% convertible notes, above its initial $400M plan, with proceeds aimed at debt repayment and capital spending.
There is no clean earnings-style consensus for this financing. The relevant benchmark is BKV’s initial September 9 announcement of a $400 million convertible offering with a $60 million overallotment; the priced deal increased both amounts. The filing states, “The offering size was increased from the previously announced offering size of $400million aggregate principal amount of Notes.”
| Term | Priced offering |
|---|---|
| Principal amount | $500 million (Financial terms) |
| Overallotment option | Up to $75 million (Financial terms) |
| Coupon / maturity | 1.625% / October 15, 2031 (Financial terms) |
| Initial conversion price | Approximately $31.93 per share, a 32.5% premium to $24.10 (Financial terms) |
| Estimated net proceeds | $481.8 million, or $554.7 million with full option exercise (Use of proceeds) |
| Capped-call price | $48.20 per share, a 100% premium to $24.10 (Capped Call Transactions) |
BKV achieved a larger raise than initially planned. The $500 million base deal is $100 million above the original proposal, while the additional-purchase option rose to $75 million from $60 million, indicating sufficient demand or favorable execution conditions. The transaction is scheduled to settle on September 14, 2026. 〔0〕
The financing is relatively light on near-term cash interest but still adds senior obligations. The notes carry a 1.625% coupon and generate an estimated $481.8 million of net proceeds, with the remainder directed to general corporate purposes including debt repayment and capital expenditures. BKV also plans to use approximately $35 million to repurchase 1,452,282 shares.
Potential dilution is meaningfully delayed and partly hedged, not eliminated. The initial conversion price is 32.5% above the September 9 share price, and capped calls are designed to offset dilution generally up to $48.20 per share. Above that cap, dilution and excess conversion payments can still emerge; the notes also remain senior, unsecured debt through 2031.
Net read: a mixed financing outcome, not a conventional beat. Relative to the only clear expectation—the initial $400 million proposal—BKV secured more capital on a low coupon and with a higher conversion premium. The tradeoff is an additional $500 million of convertible debt and future dilution exposure, so the filing improves funding flexibility without producing an unambiguously favorable capital-structure signal.
Note settlement scheduled for September 14, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!